Latest On Apyx Medical Corporation (APYX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 16:38 EST | News | Apyx Medical beats Q1 top and bottom line estimates; updates FY23 outlook | N/A |  |
| 2023-05-11 16:38 EST | News | Apyx Medical Corporation (APYX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-02 19:43 EST | News | Apyx gets FDA nod for Renuvion APR Handpiece use after liposuction | N/A | |
| 2023-04-28 16:44 EST | News | Apyx stock rises on FDA clearance of Renuvion APR Handpiece | N/A | |
| 2023-03-16 14:18 EST | News | Apyx Medical GAAP EPS of -$0.17 misses by $0.03, revenue of $12.61M misses by $0.43M | N/A | |
| 2023-03-16 14:18 EST | News | Apyx Medical Corporation (APYX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-27 11:31 EST | News | Apyx Medical wins FDA nod for Renuvion APR Handpiece in new indication | N/A | |
| 2023-02-21 21:30 EST | News | Apyx Medical to secure up to $35M credit on agreement with MidCap Financial | N/A | |
| 2023-02-01 13:44 EST | News | Apyx files for FDA expanded approval of Renuvion APR Handpiece | N/A | |
| 2023-01-10 19:47 EST | News | Apyx Medical trims FY revenue guidance, guides Q4 and FY revenue outlook below estimates | N/A | |
| 2022-11-14 05:19 EST | News | Apyx Medical Corporation (APYX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-10 12:58 EST | News | Apyx Medical reports Q3 earnings miss; narrows FY22 revenue guidance below estimates | N/A | |
| 2022-11-10 12:56 EST | News | Apyx crashes 64% as Q3 sees prolonged impact on Advanced Energy products; cuts outlook | N/A | |
| 2022-08-14 19:08 EST | News | Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-11 22:51 EST | News | Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M | N/A | |
| 2022-07-18 08:28 EST | News | Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin | N/A | |
| 2022-05-27 00:36 EST | News | Apyx Medical gains as FDA clears Renuvion for wrinkle reduction | N/A | |
| 2022-05-13 07:05 EST | News | Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-12 12:44 EST | News | Apyx Medical GAAP EPS of -$0.17, revenue of $12.5M | N/A | |
| 2022-04-04 13:52 EST | News | Apyx Medical seeks FDA nod to expand use of Renuvion to improve lax skin | N/A | |
| 2022-03-18 11:47 EST | News | Apyx Medical GAAP EPS of -$0.06 beats by $0.05, revenue of $16.82M beats by $0.47M | N/A | |
| 2022-03-18 11:46 EST | News | Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-14 23:38 EST | News | Apyx Medical sinks on safety concern for product technology | N/A | |
| 2022-01-10 15:39 EST | News | Apyx Medical to report over 40% growth in revenue, easily beat estimates: Q4 Prelim | N/A | |
| 2021-11-12 16:46 EST | News | Apyx Medical Corp (APYX) CEO Charles Goodwin on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-09-21 12:09 EST | News | Apyx Medical EPS beats by $0.03, beats on revenue | N/A | |
| 2021-08-12 12:16 EST | News | Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-03-31 16:42 EST | News | Apyx Medical EPS beats by $0.12, beats on revenue; outlook | N/A | |
| 2021-03-31 16:41 EST | News | Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-10 07:08 EST | Analyst Rating | The Analyst Target Price has increased from $11.25 to $12.5. | Buy | |
| 2021-02-01 07:08 EST | Analyst Rating | The Analyst Target Price has increased from $10.25 to $11.25. | Buy | |
| 2021-01-20 07:07 EST | Analyst Rating | The Analyst Target Price has increased from $9.25 to $10.25. | Buy | |
| 2021-01-15 07:07 EST | Analyst Rating | The Analyst Target Price has increased from $8.75 to $9.25. | Neutral | |
| 2021-01-14 00:48 EST | News | Apyx Medical rallies on Q4 and FY 2020 preliminary revenue results | N/A | |
| 2020-12-13 03:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-24 13:49 EST | News | Apyx Medical on go with Phase II of U.S. IDE study | N/A | |
| 2020-11-18 06:54 EST | News | Apyx Medical (APYX) Investor Presentation - Slideshow | N/A | |
| 2020-11-15 11:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 19:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 03:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 11:12 EST | Earnings Estimate | An EPS average of -$0.14 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-10 11:12 EST | Analyst Rating | The Analyst Target Price has increased from $8.25 to $8.75. | Buy | |
| 2020-11-10 06:18 EST | News | Apyx Medical EPS beats by $0.06, beats on revenue | N/A | |
| 2020-11-10 06:17 EST | News | Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-01 17:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 04:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 12:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 04:09 EST | Analyst Rating | The Analyst Target Price has increased from $7.75 to $8.25. | Buy | |
| 2020-08-11 07:34 EST | News | Apyx Medical EPS beats by $0.07, beats on revenue | N/A | |
| 2020-08-11 07:32 EST | News | Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q2 2020 Results - Earnings Call Transcript | N/A | |
About Apyx Medical Corporation (APYX):
Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
General
- Name Apyx Medical Corporation
- Symbol APYX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 266
- Fiscal Year EndDecember
- IPO Date1987-01-01
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://apyxmedical.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 15.18
- Price/Book (Most Recent Quarter) 5.84
- Enterprise Value Revenue 13.5
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.15
- Profit Margin -64%
- Operating Margin -97%
- Return on Assets -18%
- Return on Equity -22%
- Revenue 24.63 million
- Earnings Per Share $1.68
- Revenue Per Share $0.72
- Gross Profit 19.09 million
- Quarterly Earnings Growth -8.2%
View More
Highlights
- Market Capitalization 359.54 million
- EBITDA -16260000
- Analyst Target Price $12.5
- Book Value Per Share $1.88
View More
Share Statistics
- Shares Outstanding 34.27 million
- Shares Float 23.37 million
- % Held by Insiders 1239%
- % Held by Institutions 51.99%
- Shares Short 623736
- Shares Short Prior Month 565464
- Short Ratio 7.41
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 0.68
- 52 Week High $12.01
- 52 Week Low $2.81
- 50 Day Moving Average 10.46
- 200 Day Moving Average 7.58
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Apyx Medical Corporation (APYX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Apyx Medical Corporation (APYX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-09 | $6.95 million | -$0.11 | -$0.17 | 33.33% |
| 2020-06-30 | 2020-08-10 | $4.3 million | -$0.14 | -$0.21 | 34.12% |
| 2020-03-31 | 2020-05-11 | $5 million | -$0.06 | -$0.25 | 76% |
| 2019-12-31 | 2020-03-16 | $8.38 million | -$0.16 | -$0.19 | 17.23% |
| 2019-09-30 | 2019-11-11 | $7.58 million | -$0.13 | -$0.18 | 27.78% |
| 2019-06-30 | 2019-08-07 | $6.57 million | -$0.13 | -$0.18 | 26.76% |
| 2019-03-31 | 2019-05-08 | $5.82 million | -$0.14 | -$0.17 | 16.02% |
| 2018-12-31 | 2019-03-13 | $5.93 million | -$0.12 | -$0.10 | -17.07% |
| 2018-09-30 | 2018-11-01 | $3.67 million | $1.98 | -$0.09 | 2240.54% |
| 2018-06-30 | 2018-08-01 | $11.48 million | -$0.01 | -$0.03 | 66.67% |
| 2018-03-31 | 2018-05-14 | $9.92 million | -$0.03 | -$0.02 | -28.76% |
| 2017-12-31 | 2018-03-12 | $11.35 million | -$0.03 | -$0.07 | 53.85% |
| 2017-09-30 | 2017-11-02 | $9.35 million | -$0.04 | -$0.01 | -200.75% |
| 2017-06-30 | 2017-08-02 | $9.8 million | -$0.04 | -$0.03 | -20.12% |
| 2017-03-31 | 2017-05-15 | $8.39 million | -$0.05 | -$0.04 | -42.86% |
| 2016-12-31 | 2017-03-09 | $9.49 million | -$0.02 | -$0.01 | -100% |
| 2016-09-30 | 2016-10-26 | $10.06 million | -$0.04 | -$0.03 | -60% |
| 2016-06-30 | 2016-08-01 | $9.3 million | -$0.02 | -$0.06 | 63.64% |
| 2016-03-31 | 2016-05-11 | $7.78 million | -$0.07 | -$0.06 | -27.27% |
| 2015-12-31 | 2016-03-17 | $8.29 million | -$0.05 | -$0.07 | 23.08% |
| 2015-09-30 | 2015-11-04 | $7.82 million | -$0.07 | -$0.06 | -16.67% |
| 2015-06-30 | 2015-08-06 | $7.27 million | -$0.06 | -$0.09 | 33.33% |
| 2015-03-31 | 2015-05-08 | $6.13 million | -$0.14 | -$0.10 | -40% |
| 2014-12-31 | 2015-02-27 | $7.47 million | -$0.27 | ||
| 2014-09-30 | 2014-11-06 | $6.79 million | -$0.17 | ||
| 2014-06-30 | 2014-08-05 | $6.95 million | -$0.03 | -$0.02 | -50% |
| 2014-03-31 | 2014-05-15 | $6.48 million | -$0.01 | -$0.05 | 80% |
| 2013-09-30 | 2013-11-14 | $5.79 million | -$0.02 | ||
| 2013-06-30 | 2013-08-14 | $6.04 million | -$0.06 | ||
| 2013-03-31 | 2013-04-01 | $5.7 million | $0.02 | $0.02 | 0% |
| 2012-12-31 | 2013-03-31 | $6.83 million | $0.02 | $0.02 | 0% |
| 2012-09-30 | 2012-11-14 | $6.67 million | $-0.00 | ||
| 2012-06-30 | 2012-08-14 | $7.44 million | $0.01 | ||
| 2012-03-31 | 2012-05-15 | $6.73 million | $0.01 | ||
| 2011-12-31 | 2012-03-29 | $6.16 million | -$0.05 | ||
| 2011-09-30 | 2011-11-14 | $6.26 million | $0.00 | ||
| 2011-06-30 | 2011-08-12 | $6.84 million | $0.02 | ||
| 2011-03-31 | 2011-05-12 | $6.15 million | $0.03 | ||
| 2010-09-30 | 2010-11-09 | $6.5 million | $0.00 | ||
| 2010-06-30 | 2010-08-09 | $5.9 million | $0.00 | ||
| 2010-03-31 | 2010-05-10 | $5.6 million | -$0.01 | ||
| 2009-12-31 | 2010-03-16 | $6.53 million | $0.00 | ||
| 2009-09-30 | 2009-11-09 | $6.37 million | $-0.00 | $0.01 | -121% |
| 2009-06-30 | 2009-08-10 | $6.83 million | $0.01 | $0.02 | -50% |
| 2009-03-31 | 2009-05-08 | $7.22 million | $0.02 | ||
| 2008-09-30 | 2008-11-10 | $7.3 million | $0.02 | ||
| 2008-06-30 | 2008-08-13 | $6.99 million | $0.08 | ||
| 2008-03-31 | 2008-05-14 | $6.68 million | $0.01 | ||
| 2007-09-30 | 2007-11-12 | $7.46 million | $0.03 | ||
| 2007-06-30 | 2007-08-10 | $7.44 million | $0.06 | ||
| 2007-03-31 | 2007-05-15 | $6.7 million | $0.03 | ||
| 2006-09-30 | 2006-11-07 | $7 million | $0.05 | ||
| 2006-06-30 | 2006-08-09 | $6.74 million | $0.04 | ||
| 2006-03-31 | 2006-05-10 | $6.01 million | $0.04 | ||
| 2005-12-31 | 2006-03-29 | $5.37 million | $0.02 | ||
| 2005-09-30 | 2005-11-14 | $5.04 million | $0.01 | ||
| 2005-06-30 | 2005-08-15 | $5.06 million | -$0.01 | ||
| 2005-03-31 | 2005-05-13 | $4.74 million | $0.01 | ||
| 2004-12-31 | 2005-03-29 | $4.87 million | $0.02 | ||
| 2004-09-30 | 2004-11-14 | $5.62 million | $0.03 | ||
| 2004-06-30 | 2004-08-15 | $5.27 million | $0.03 | ||
| 2004-03-31 | 2004-05-13 | $4.74 million | $0.01 | ||
| 2003-12-31 | 2004-03-30 | $4.12 million | -$0.02 | ||
| 2003-09-30 | 2003-11-03 | $4.04 million | $0.03 | ||
| 2003-06-30 | 2003-07-30 | $4.28 million | $0.03 | ||
| 2003-03-31 | 2003-03-31 | $3.67 million | $0.00 | ||
| 2002-09-30 | 2002-09-30 | $3.05 million | $-0.00 | ||
| 2002-06-30 | 2002-06-30 | $3.2 million | $-0.00 | ||
| 2002-03-31 | 2002-03-31 | $3.03 million | $-0.00 | ||
| 2001-09-30 | 2001-09-30 | $2.78 million | $0.02 | ||
| 2001-06-30 | 2001-06-30 | $2.82 million | $0.01 | ||
| 2001-03-31 | 2001-03-31 | $2.74 million | $0.01 | ||
| 2000-09-30 | 2000-09-30 | $2.49 million | $0.01 | ||
| 2000-06-30 | 2000-06-30 | $2.43 million | $0.02 | ||
| 2000-03-31 | 2000-03-31 | $2.17 million | $0.00 | ||
| 1999-09-30 | 1999-09-30 | -$0.11 | |||
| 1999-06-30 | 1999-06-30 | $0.01 | |||
| 1999-03-31 | 1999-03-31 | $0.00 | |||
| 1998-03-31 | 1998-03-31 | -$0.01 |
Apyx Medical Corporation (APYX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | 1.05 million | 975000 | 980000 | 1.1 million | 936000 |
| Income Before Tax | -4.45 million | -6.18 million | -6.86 million | -5.82 million | -4.14 million |
| Selling General Administrative | 8.05 million | 7.29 million | 9.5 million | 10.43 million | 8.78 million |
| Gross Profit | 4.73 million | 2.09 million | 2.98 million | 5.56 million | 5.02 million |
| Ebit | -4.42 million | -5.95 million | -6.64 million | -5.96 million | -4.7 million |
| Operating Income | -4.37 million | -6.17 million | -7.49 million | -5.96 million | -4.7 million |
| Income Tax Expense | N/A | -1.49 million | N/A | -383000 | 171000 |
| Total Revenue | 6.95 million | 4.3 million | 5 million | 8.38 million | 7.58 million |
| Cost of Revenue | 2.23 million | 2.2 million | 2.01 million | 2.82 million | 2.56 million |
| Total Other Income Expense Net | -63000 | -14000 | 426000 | 145000 | 557000 |
| Net Income From Continuing Operations | -3.73 million | -4.69 million | -1.95 million | -5.43 million | -4.31 million |
| Net Income Applicable to Common Shares | N/A | -4.69 million | N/A | -5.43 million | -4.31 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | -94000 | -90000 | N/A | N/A |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | -63000 | 15000 | N/A | N/A |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | N/A | -5.22 million | -7.43 million | N/A | N/A |
| Total Cash from Operating Activities | N/A | -5.03 million | -7.41 million | N/A | N/A |
| Depreciation | N/A | 225000 | 214000 | N/A | N/A |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | 284000 | -855000 | N/A | N/A |
| Change to Account Receivables | N/A | -325000 | 1.52 million | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | 94000 | 90000 | N/A | N/A |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 11.08 million | N/A | 11.69 million | 13.42 million | 10.21 million |
| Total Stockholder Equity | 64.2 million | N/A | 70.43 million | 71.26 million | 76.73 million |
| Other Current Liabilities | N/A | N/A | 1.53 million | N/A | N/A |
| Total Assets | 75.42 million | N/A | 82.12 million | 84.68 million | 86.94 million |
| Common Stock | N/A | 34000 | N/A | 34000 | 34000 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | 4.15 million | 7.88 million | 12.57 million | 14.52 million | 21.03 million |
| Other Liabilities | N/A | 765000 | N/A | 519000 | 339000 |
| Other Assets | N/A | 560000 | N/A | 391000 | 387000 |
| Cash | 43.54 million | N/A | 51.38 million | 58.81 million | 62.27 million |
| Total Current Liabilities | 9.59 million | N/A | 10.6 million | 12.24 million | 9.04 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | N/A | 7.43 million | N/A | 7.62 million | 7.65 million |
| Total Current Assets | 67.66 million | N/A | 74.17 million | 76.66 million | 78.91 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | N/A | 66.84 million | N/A | 71.26 million | 76.73 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | 140000 |
| Inventory | 5.42 million | N/A | 5.87 million | 5.05 million | 7.24 million |
| Accounts Payable | 2.48 million | N/A | 2.54 million | 2.37 million | 1.46 million |
Apyx Medical Corporation (APYX) Chart:
Apyx Medical Corporation (APYX) News:
Below you will find a list of latest news for Apyx Medical Corporation (APYX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Apyx Medical Corporation (APYX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.05 | CALL | 0 | 100 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0.1 | CALL | 0 | 251 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.2 | CALL | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.9 | PUT | 0 | 60 | 168.16 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 371.79 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 449.22 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.05 | CALL | 0 | 1011 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0.05 | CALL | 0 | 13 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.2 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.85 | PUT | 0 | 51 | 108.55 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 236.94 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 288.13 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.15 | CALL | 0 | 11 | 117.53 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 103.27 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0 | PUT | 0 | 0 | 150.3 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 215.18 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | CALL | 0 | 0 | 110.09 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 0 | CALL | 0 | 0 | 121.26 | FALSE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 106.63 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 0 | PUT | 0 | 0 | 120.84 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | PUT | 0 | 0 | 151.95 | TRUE | 0 | 0 |
| 2024-12-20 | 2.5 | 0.3 | CALL | 0 | 4023 | 111.85 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 0.6 | CALL | 0 | 109 | 125.66 | FALSE | 0 | 0 |
| 2024-12-20 | 7.5 | 0.15 | CALL | 0 | 3513 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | PUT | 0 | 0 | 99.94 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 3.5 | PUT | 0 | 10 | 114.45 | TRUE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | PUT | 0 | 0 | 144.01 | TRUE | 0 | 0 |
Latest APYX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:58 PM EST | 21 | $6.215 |
| Jun 13, 2022 7:59 PM EST | 100 | $6.215 |
| Jun 13, 2022 7:59 PM EST | 100 | $6.215 |
| Jun 13, 2022 7:59 PM EST | 100 | $6.215 |
| Jun 13, 2022 7:59 PM EST | 100 | $6.215 |
Apyx Medical Corporation (APYX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/719135/000071913520000051/0000719135-20-000051-index.htm |
| 2018-05-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/719135/000000000018014465/0000000000-18-014465-index.htm |
| 2017-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913517000067/0000719135-17-000067-index.htm |
| 2017-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913517000070/0000719135-17-000070-index.htm |
| 2018-01-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000002/0000719135-18-000002-index.htm |
| 2018-01-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000004/0000719135-18-000004-index.htm |
| 2018-01-23 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/719135/000071913518000008/0000719135-18-000008-index.htm |
| 2018-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000013/0000719135-18-000013-index.htm |
| 2018-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/719135/000071913518000015/0000719135-18-000015-index.htm |
| 2018-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000017/0000719135-18-000017-index.htm |
| 2018-04-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000019/0000719135-18-000019-index.htm |
| 2018-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000021/0000719135-18-000021-index.htm |
| 2018-05-04 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/719135/000071913518000024/0000719135-18-000024-index.htm |
| 2018-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000028/0000719135-18-000028-index.htm |
| 2018-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913518000030/0000719135-18-000030-index.htm |
| 2018-05-16 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/719135/000071913518000035/0000719135-18-000035-index.htm |
| 2018-05-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/719135/000071913518000037/0000719135-18-000037-index.htm |
| 2018-05-24 | SD | https://www.sec.gov/Archives/edgar/data/719135/000071913518000039/0000719135-18-000039-index.htm | |
| 2018-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000044/0000719135-18-000044-index.htm |
| 2018-07-17 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/719135/000071913518000046/0000719135-18-000046-index.htm |
| 2018-07-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/719135/000071913518000050/0000719135-18-000050-index.htm |
| 2018-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000054/0000719135-18-000054-index.htm |
| 2018-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913518000055/0000719135-18-000055-index.htm |
| 2018-08-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000057/0000719135-18-000057-index.htm |
| 2018-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000059/0000719135-18-000059-index.htm |
| 2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000065/0000719135-18-000065-index.htm |
| 2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000066/0000719135-18-000066-index.htm |
| 2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000067/0000719135-18-000067-index.htm |
| 2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000068/0000719135-18-000068-index.htm |
| 2018-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000069/0000719135-18-000069-index.htm |
| 2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000073/0000719135-18-000073-index.htm |
| 2018-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913518000076/0000719135-18-000076-index.htm |
| 2018-11-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000078/0000719135-18-000078-index.htm |
| 2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000080/0000719135-18-000080-index.htm |
| 2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000082/0000719135-18-000082-index.htm |
| 2018-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000084/0000719135-18-000084-index.htm |
| 2018-12-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913518000086/0000719135-18-000086-index.htm |
| 2018-12-31 | 25 | Notification of the removal from listing and registration of matured, redeemed or retired securities | https://www.sec.gov/Archives/edgar/data/719135/000071913518000089/0000719135-18-000089-index.htm |
| 2018-12-31 | 8-A12B/A | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/719135/000071913518000090/0000719135-18-000090-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000004/0000719135-19-000004-index.htm |
| 2019-01-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000006/0000719135-19-000006-index.htm |
| 2019-01-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000008/0000719135-19-000008-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000010/0000719135-19-000010-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000012/0000719135-19-000012-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000014/0000719135-19-000014-index.htm |
| 2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000016/0000719135-19-000016-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913519000019/0000719135-19-000019-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000020/0000719135-19-000020-index.htm |
| 2019-05-31 | SD | https://www.sec.gov/Archives/edgar/data/719135/000071913519000022/0000719135-19-000022-index.htm | |
| 2019-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000025/0000719135-19-000025-index.htm |
| 2019-06-21 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/719135/000071913519000027/0000719135-19-000027-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000029/0000719135-19-000029-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000031/0000719135-19-000031-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000033/0000719135-19-000033-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000035/0000719135-19-000035-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000037/0000719135-19-000037-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000038/0000719135-19-000038-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913519000039/0000719135-19-000039-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000040/0000719135-19-000040-index.htm |
| 2019-08-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913519000042/0000719135-19-000042-index.htm |
| 2019-09-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/719135/000071913519000044/0000719135-19-000044-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000047/0000719135-19-000047-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000048/0000719135-19-000048-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000053/0000719135-19-000053-index.htm |
| 2019-11-13 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/719135/000071913519000056/0000719135-19-000056-index.htm |
| 2019-11-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913519000060/0000719135-19-000060-index.htm |
| 2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913519000063/0000719135-19-000063-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913520000002/0000719135-20-000002-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000007/0000719135-20-000007-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000008/0000719135-20-000008-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000009/0000719135-20-000009-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000010/0000719135-20-000010-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000012/0000719135-20-000012-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000014/0000719135-20-000014-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000016/0000719135-20-000016-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913520000022/0000719135-20-000022-index.htm |
| 2020-03-16 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/719135/000071913520000023/0000719135-20-000023-index.htm |
| 2020-03-19 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913520000026/0000719135-20-000026-index.htm |
| 2020-03-31 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/719135/000071913520000029/0000719135-20-000029-index.htm |
| 2020-05-08 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913520000035/0000719135-20-000035-index.htm |
| 2020-05-08 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913520000036/0000719135-20-000036-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913520000042/0000719135-20-000042-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913520000043/0000719135-20-000043-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000045/0000719135-20-000045-index.htm |
| 2020-06-01 | SD | https://www.sec.gov/Archives/edgar/data/719135/000071913520000047/0000719135-20-000047-index.htm | |
| 2020-06-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/719135/000071913520000049/0000719135-20-000049-index.htm |
| 2020-06-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/719135/000071913520000051/0000719135-20-000051-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913520000054/0000719135-20-000054-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/719135/000071913520000057/0000719135-20-000057-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913520000058/0000719135-20-000058-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000059/0000719135-20-000059-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000060/0000719135-20-000060-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000061/0000719135-20-000061-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000062/0000719135-20-000062-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/719135/000071913520000063/0000719135-20-000063-index.htm |
| 2020-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913520000067/0000719135-20-000067-index.htm |
| 2020-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000071913520000070/0000719135-20-000070-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000083423720007976/0000834237-20-007976-index.htm |
| 2018-02-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000091957418000970/0000919574-18-000970-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000091957419001301/0000919574-19-001301-index.htm |
| 2019-04-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000091957419002790/0000919574-19-002790-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000091957420001138/0000919574-20-001138-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000093041318000476/0000930413-18-000476-index.htm |
| 2018-02-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000119312518037488/0001193125-18-037488-index.htm |
| 2019-01-18 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000119312519011979/0001193125-19-011979-index.htm |
| 2020-01-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000119312520004330/0001193125-20-004330-index.htm |
| 2019-01-02 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/719135/000135445719000001/0001354457-19-000001-index.htm |
| 2018-01-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000149315218000367/0001493152-18-000367-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000149315218002078/0001493152-18-002078-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000149315219001943/0001493152-19-001943-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/719135/000149315220002398/0001493152-20-002398-index.htm |
| 2019-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000162828019000624/0001628280-19-000624-index.htm |
| 2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000162828019002891/0001628280-19-002891-index.htm |
| 2019-03-14 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/719135/000162828019002892/0001628280-19-002892-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000162828019003915/0001628280-19-003915-index.htm |
| 2019-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/719135/000162828019004808/0001628280-19-004808-index.htm |
| 2018-09-27 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/719135/000168499518000013/0001684995-18-000013-index.htm |
| 2019-01-28 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/719135/000168499519000001/0001684995-19-000001-index.htm |
| 2018-05-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/719135/999999999518001275/9999999995-18-001275-index.htm |
Apyx Medical Corporation (APYX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apyx Medical Corporation (APYX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1239%Institutional Ownership: 5199%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-05-13 | Charles D. II Goodwin | Chief Executive Officer | Buy | 28,250.00 | 3.30 | 93,196.75 | 28,250.00 | https://www.sec.gov/Archives/edgar/data/719135/000071913520000045/0000719135-20-000045-index.htm |